Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2022
Addex and Indivior extend GABAB PAM collaboration
Addex Therapeutics reported that its strategic collaboration with Indivior on GABAB PAM had been extended with an additional $4 million in funding.
2020
Addex appoints Darryle D. Schoepp to chair its scientific advisory board
Addex reported that it appointed Darryle D. Schoepp as chair of its newly formed scientific advisory board. The source does not give the appointment date.
2020
Addex Therapeutics reports first-quarter 2020 results
Addex Therapeutics reported first-quarter 2020 financial results for the period ended March 31, 2020, including a net loss of CHF 4.306 million and cash and cash equivalents of CHF 27.126 million.